Summary: Regional cerebral blood flow (rCBF) was measured by the xenon-133 inhalation method in an un selected group of nine chronic hemodialysis patients be fore and after a single hemodialytic treatment. All pa tients underwent neurological, neuropsychological, and biochemical evaluations on the same occasions. Predial ysis rCBF values did not differ from those obtained in age-matched normal controls. Following hemodialysis, there was a mild reduction in the rCBF by a mean of 7 ± Although chronic hemodialysis prevents uremic encephalopathy, it may nevertheless cause other neurologic complications. These include the dis equilibrium syndrome (Peterson and Swanson, 1964) and the progressive syndrome of dialysis en cephalopathy (dialysis dementia) (Lederman and Henry, 1978) , as well as a greater tendency for sub dural hematoma (Adams and Victor, 1985) . The dis equilibrium syndrome is attributed to water shift into the brain, usually in patients undergoing rapid dialysis. Subacute evolution of speech distur bances, myoclonus, dementia seizures, and gait difficulties are the main features of progressive dial ysis encephalopathy. The mechanisms responsible for the development of this complication are unde termined. Regional cerebral blood flow changes have been found in other metabolic (e. g. , hepatic) encephalopathies (Baldy-Moulinier and Bories, 1962), but it has never been investigated in chronic hemodialytic encephalopathy. We therefore exam ined whether or not hemodialysis may cause a change in the rCBF and whether or not these 2.6% (p = 0.02). The posthemodialysis rCBF reduction was not associated with any neurological or cognitive dysfunction. The causes of hemodialysis-induced rCBF decreases are unknown, but increased blood viscosity and biochemical changes, such as urea reduction and blood alkalinization, may play a role. Key Words: Encephalopathy -Hemodialysis-Metabolic changes rCBF.
changes are correlated with signs of neurological and mental deterioration.
MATERIALS AND METHODS
Nine patients on chronic maintenance hemodialysis (4 men and 5 women, mean age 50 ± 22 years) underwent rCBF measurements, as well as neurological and cogni tive evaluation, immediately before and after a single he modialytic treatment. Blood count, electrolytes, renal and hepatic functions, and arterial blood gases were deter mined on the same occasions. All patients suffered from chronic renal failure due to diverse etiologies (Table 1) . Disease duration ranged from 2 to 20 years (average 7.5 years). Hemodialytic treatment duration ranged from 6 months to lO years (average 3.6 years) and was adminis tered 3 times a week for 3-4 h each time. None of the patients suffered from any central nervous system abnor malities, and none had overt signs of hemodialytic en cephalopathy. Psychological evaluation included a Mini Mental test and a battery of tests for memory, language, visual organization, construction, and manipulation of knowledge. Measurements of rCBF were performed using the xenon-133 inhalation technique (Obrist et aI., 1975) . The study was conducted with subjects at rest, in a quiet semidarkened room. Xenon-133, in a concentration of 2.5 mCi/L mixed with air, was breathed by the subject for 1 min through a close-fitting face mask with a one-way valve. Clearance of radioisotope from brain was moni tored for lO min by 16 NaI-collimated scintillation de tectors applied perpendicularly over homologous regions in both hemispheres. Flow values were calculated as the glomerulonephritis initial slope index (lSI) according to Risberg (Risberg et ai., 1975) . All results were compared to a control group composed of 44 mentally and neurologically normal, non hospitalized subjects, aged 49-79 years. Informed con sent was received for all examinations.
RESULTS
As a whole group, initial predialysis mean brain CBF, mean left and right hemispheric CBF, and re gional flow values in hemodialysis patients did not differ significantly from those obtained in age matched controls. Correlation of rCBF values with age within the group of patients showed an age-re lated disease, as previously reported in a normal population. Although the cause and duration of the renal disorder had no effect on the rCBF, there was some influence of hemodialysis duration. Three pa tients who were under dialysis for more than 2 years had a significant reduction in the rCBF as compared with age-matched control values by a mean of 16.6 ± 7%. Following hemodialysis, mean brain CBF decreased in 8 of 9 patients. For the whole group, the decrease was by a mean of 7 ± 2.6% as compared with predialysis values (p = 0.02, t test). There was a decrease by a mean of 7.5 ± 2.5% in the difference of predialysis and postdi alysis rCBF deviations from the normal age matched control values ( 3.3% due to hemoconcentration, a mean reduction of blood urea nitrogen by a mean of 12.8 ± 3.9 mmol/L, and an increase of arterial blood pH from a mean of 7.32 ± 0.05 to a mean of 7.40 ± 0.08.
Mean predialysis P a co2 values were 30 mm Hg, and they increased to a postdialysis mean of 35 mm Hg.
Most patients started hemodialysis with an elevated arterial blood pressure (mean arterial blood pres sure of 114 ± 5 mm Hg). In all patients, the blood pressure decreased after hemodialysis (mean arte rial blood pressure of 98 ± 5 mm Hg). No clear correlation was found between any single biochem ical and blood pressure change and pre dialytic rCBF values or postdialytic rCBF reduction. 
DISCUSSION
These preliminary results in a rather small group of chronic hemodialytic patients indicate that predi alysis rCBF values do not differ from those ob tained in age-matched normal controls. However, in such patients, a single hemodialytic treatment may induce reduction in the rCBF. The duration of this hemodialysis-induced rCBF decrease is un known, but as patients received their treatments at 48-72-h intervals, it cannot last longer. There were no neurological and cognitive alterations associated with these rCBF changes. However, predialysis neuropsychological score was mildly reduced as compared with those in normal controls, in confir mation of other studies (Gilli and De Bontiani, 1983 ).
The causes of hemodialysis-induced rCBF reduc tions are at present unknown. A single hemodia lytic treatment is associated with a variety of bio chemical and physiological changes (Hakim and Michel, 1986 ; also our results). Although we did not find a correlation between rCBF reduction and any single biochemical factor, it may be explained by a combination of these changes. A possible mecha nism may include increased hemoconcentration and blood viscosity following hemodialysis (Humphrey, 1981) . The change in blood acidity to ward alkalinization (Olesen, 1974) and reduction in blood concentration of humoral vasoactive factors, such as urea (Rapela and Bugnsky, 1969) , may also play a role. Most patients were hypertensive, and in all of them, hemodialysis caused a reduction in arterial blood pressure. This blood pressure reduc tion could have caused rCBF decreases, but this would imply a dysfunction of CBF autoregulation, and this possibility remains to be investigated.
The evidence for rCBF changes during a single hemodialytic treatment suggests the need for fur ther evaluation of a larger number of patients and particularly those developing chronic hemodialysis encephalopathy. It may be found that in these groups of patients, a more pronounced posthemo dialytic rCBF reduction may occur.
